...
首页> 外文期刊>Pharmacological research: The official journal of The Italian Pharmacological Society >Mitochondrial bioenergetics, redox state, dynamics and turnover alterations in renal mass reduction models of chronic kidney diseases and their possible implications in the progression of this illness
【24h】

Mitochondrial bioenergetics, redox state, dynamics and turnover alterations in renal mass reduction models of chronic kidney diseases and their possible implications in the progression of this illness

机译:慢性肾病肾调量模型的线粒体生物植物,氧化还原状态,动力学和周转改变及其在这种疾病进展中的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Nowadays, chronic kidney disease (CKD) is considered a worldwide public health problem. CKD is a term used to describe a set of pathologies that structurally and functionally affect the kidney, it is mostly characterized by the progressive loss of kidney function. Current therapeutic approaches are insufficient to avoid the development of this disease, which highlights the necessity of developing new strategies to reverse or at least delay CKD progression. Kidney is highly dependent on mitochondrial homeostasis and function, consequently, the idea that mitochondrial pathologies could play a pivotal role in the genesis and development of kidney diseases has risen. Although many research groups have recently published studies of mitochondrial function in acute kidney disease models, the existing information about CKD is still limited, especially in renal mass reduction (RMR) models. This paper focuses on reviewing current experimental information about the bioenergetics, dynamics (fission and fusion processes), turnover (mitophagy and biogenesis) and redox mitochondrial alterations in RMR, to discuss and integrate the mitochondrial changes triggered by nephron loss, as well as its relationship with loss of kidney function in CKD, in these models. Understanding these mechanisms would allow us to design new therapies that target these mitochondrial alterations.
机译:如今,慢性肾病(CKD)被认为是全球公共卫生问题。 CKD是用于描述一组在结构上和功能上影响肾脏的一组病理的术语,其主要是肾功能逐渐丧失的特征。目前的治疗方法不足以避免这种疾病的发展,这突出了开发逆转或至少延迟CKD进展的新策略的必要性。因此,肾脏高度依赖于线粒体稳态和功能,因此,线粒体病理在肾病的成因和发育中可能发挥关键作用的想法已经上升。尽管许多研究组最近公布了对急性肾病模型中线粒体功能的研究,但CKD的现有信息仍然有限,特别是在肾脏质量减少(RMR)模型中。本文侧重于审查有关生物能源,动力学(裂变和融合过程)的当前实验信息,RMR中的营业额(MITOCHAY和BIENCAINCE)和氧化还原线粒体改变,讨论和整合由肾小球损失引发的线粒体变化,以及其关系随着CKD的损失,在这些模型中。了解这些机制允许我们设计针对这些线粒体改变的新疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号